u/emil_agyeman

SGN ships from Denmark, arrival is 18 to 32 days on average

STEP, SURMOUNT, SURPASS, SELECT, FLOW, TRIUMPH — read the appendix

ferritin tanks quietly on a reduced appetite, check it

retatrutide is not approved anywhere for human use, posts must not read as instructions

the 12.5mg arm is different from 15mg, results do not transfer

Disagree on that part. 93.7% and 99.3% on the same vial is normal.

Research use material only, no human-use approval anywhere. Posts must describe what happened, not instruct strangers.

This is the "correlation is mechanism" thing again. You changed three variables at once.

STEP 1 readout: 98.3% mean weight loss, absolute numbers matter. Spread around that mean is enormous.

nobody here can tell you what a result means for you

TRIUMPH data is phase 2, not phase 3, smaller n and shorter

Second this question. I have wondered about weekly update for 10 months and never seen a straight answer.

the dosing is steep, the injection-site soreness reports are real, and nobody knows the human safety yet

post the whole document, not the headline number

Adding to this: related substances is doing more work than the comment implies.

SELECT reported a SURMOUNT hazard ratio but the absolute event rate is what changes clinical practice.

Maintenance for 14 months now. Weight moves within about 3kg and the dose is a quarter of what it peaked at.

Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.

Every time this gets posted it hits the front page and every time someone has to re-explain it.

Disagree. What you are describing is consistent with mechanism, not with what you concluded.

Strongly agree. Heart rate escalation needs the actual data, not impressions.

Do you have baseline to compare to?